Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
Authors:
- Sean van DiepenSDSean van Diepen
- L. Kristin NewbyLNL. Kristin Newby
- Renato D. LopesRLRenato D. Lopes
- Amanda StebbinsASAmanda Stebbins
- Vic HasselbladVHVic Hasselblad
- Stefan JamesSJStefan James
- Matthew T. RoeMRMatthew T. Roe
- Justin A. EzekowitzJEJustin A. Ezekowitz
- David J. MoliternoDMDavid J. Moliterno
- Franz-Josef NeumannFNFranz-Josef Neumann
- Craig ReistCRCraig Reist
- Kenneth W. MahaffeyKMKenneth W. Mahaffey
- 1 October 2013
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 168 (3) , 2127-2133
Abstract
No abstract availableKeywords
Funding Information
- Procter and Gamble
- Alexion Pharmaceuticals
This publication has 37 references indexed in Scilit:
- A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2010
- C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarctionEuropean Heart Journal, 2009
- Clinical Implications of Elevated Serum Interleukin‐6, Soluble CD40 Ligand, Metalloproteinase‐9, and Tissue Inhibitor of Metalloproteinase‐1 in Patients with Acute ST‐segment Elevation Myocardial InfarctionClinical Cardiology, 2008
- Prediction of One-Year Mortality Among 30-Day Survivors After Primary Percutaneous Coronary InterventionsThe American Journal of Cardiology, 2006
- Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromesClinical and Experimental Medicine, 2006
- Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionJACC, 2005
- Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionAmerican Heart Journal, 2005
- Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary AngioplastyCirculation, 2004
- Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score)The American Journal of Cardiology, 2004
- Induction and suppression of interferon‐inducible protein (IP)‐10 in reperfused myocardial infarcts may regulate angiogenesisThe FASEB Journal, 2001